Monoclonal CDw6O antibodies recognize glycolipid antigens with restricted surface expression on human leukocytes. They allow us to define new functional subpopulations of T lymphocytes and are able to induce costimulatory signals. In this report, we describe the molecular composition of CDw6O glycolipid antigens derived from different human leukocyte subpopulations. The glycolipids were isolated and their structures were identified by immunochemical methods. All molecules containing the CDw6O determinant were found in the disialoganglioside fraction. They were 0-acetylated derivatives of the gangliosides 113 (Neu5Ac),-LacCer (GD3), IV3 (Ne~5Ac)~-nLc,Cer ANGLIOSIDES are sialic acid-containing glycosphin-G golipids (GSLs) consisting of an oligosaccharide chain attached to a lipid core structure; they are plasma membrane constituents of all mammalian cells. The pattern of gangliosides expressed on human hematopoietic cells is cell-type-specific'-' and is presumed to play an important role in membrane-mediated processes such as cell signaling and recognition events involved in cell differentiation: hormone receptor m~dulation,'~~ and cell-cell The function of GSLs in cellular recognition is substantiated by recent reports showing that carbohydrate sequences on both GSLs and glycoproteins are specific ligands of a group of mammalian lectins called se1ectins.lGL2 Furthermore, GSLs, particularly gangliosides, and monoclonal antibodies (MoAbs), which recognize gangliosides, have been reported to control growth and function of lymphoid cell^'^,'^ and phagocytes."
terns on the cell surface might serve as functional markers of leukocyte subpopulations. To address this question, a large number of leukocyte-specific MoAbs were screened for reactivity with glycoconjugates using complex glycolipid mixtures prepared from leukocytes. These investigations led to the definition of new clusters of MoAbs that were specific for carbohydrate differentiation antigens on the surface of leukocytes such as the myeloid cell-restricted CDw65 M o A~s , '~, '~ the B-cell-specific CD77I8*l9 and CD76" mAbs, and the T-cell-restricted CDw60 MoAbs.21,22 Previously, we have found that CDw60 mAbs define new functional subpopulations of both the CD4+ and CD8' T-cell s~b s e t s~~,~~ and that they bind to several different disialogangliosides.2' Recently, we identified one of the target structures of CDw60 MoAbs as 113 (NeuS, 9Ac2-Neu5Ac)-LacCer (9-0-acetyl GD3), which had been isolated from bovine b~t t e r m i l k . ~~ To date, this structure has mainly been reported as a melanoma-associated antigen in human^.^'-^'
In this report, an analysis of the structures and distribution of CDw60 glycolipid antigens in various human hematopoietic cell types is presented. We show that the main CDw60 glycolipid of human leukocytes is 9-0-acetyl GD3, which, in addition to T lymphocytes, is also found in the lipid extracts of other leukocyte subsets, particularly granulocytes.
(CPDA 1) anticoagulated blood. Five hundred milliliters of this pool, which represents 20 to 30 buffy coats, were centrifuged at 3,200g for 20 minutes. The white blood cell layer (-100 mL) was mixed with 50 mL citric acid, sodium citrate, and glucose (ACD) stabilizer and 100 mL Gelafundin (gelatine, molecular weight 35,000; Braun, Melsungen, Germany), distributed into glass flasks, and filled up with the plasma that was obtained during the centrifugation. After sedimentation for 6 hours at room temperature or for 24 hours at 4"C, the layer containing white blood cells was collected, diluted with an equal volume of phosphate-buffered saline (PBS), and centrifuged at 3,200g for 30 minutes. The pellet was resuspended in lysis buffer ( I 55 mmol/L NH4Cl in 10 mmol/L phosphate, pH 7.4) at 0°C for 30 minutes to lyse residual erythrocytes. Cells were washed twice in PBS, counted, taken up in ice-cold methanol, and stored at -70°C.
Isolation of leukocyte subpopulations. For preparation of granulocytes, 500-mL pooled buffy coats were centrifuged at 3,200g for 20 minutes and the white blood cell layer (bu@ coat of the pooled buffy coats, 100 mL) was mixed with 50 mL ACD stabilizer and 200 mL Gelafundin and sedimented 1 hour at 20°C in glass tubes. The supernatant containing all leukocytes and some red blood cells was centrifuged at 1 ,Doog for 45 minutes, and the red blood cells in the pellet were lysed as previously described. The remaining cells were resuspended in PBS and centrifuged on a density gradient (Lymphoprep, Nycomed, Oslo, Norway). Granulocytes were recovered as pellet and washed.
Monocytes were separated from the mononuclear fraction by plastic adherence in the presence of 2% fetal calf serum (FCS) under lipopolysaccharide-free conditions, as described previ~usly.~~ T Lymphocytes were enriched from peripheral blood mononuclear cells as rosettes with (2-aminoethyl)-isothiouronium bromidetreated sheep erythrocytes and centrifugation through a Percoll layer (Pharmacia, Freiburg, Germany) of 1.080-dmL density.
B lymphocytes were prepared from human tonsils. Tonsillar tissue was obtained from patients undergoing tonsillectomy for tonsil hyperplasia and was kindly provided by the ENT Department, University of Munich. Tonsils were cut into small pieces and minced through a stainless steel mesh. Mononuclear tonsil cells were obtained by Ficoll-Hypaque centrifugation. B lymphocytes were enriched from mononuclear cells as CD37 rosettes by the direct MoAb rosetting te~hnique.'~ Normal human thymic tissue was obtained from pediatric patients undergoing corrective cardiac surgery and was kindly provided by the surgical department of Deutsches Herzzentrum, Munich. Thymic cells were prepared by teasing small pieces of fresh thymus through a stainless steel gauge into cold RPMI 1640 medium containing FCS and 0.1 mg/mL DNase.
All leukocyte subpopulations were more than 95% pure as demonstrated by phenotyping with fluorescein isothiocyanate (FITC)-labeled CD-MoAbs and cytofluorographic analysis. After washing with PBS, cell preparations were immediately taken up in ice-cold methanol and stored at -70°C.
Glycolipids. I13(Neu5Ac),-LacCer (GD,) and 9-0-acetyl GD3 were prepared and analyzed from bovine buttermilk as previously described.24 Disialosylparagloboside ([DSPG] IV'(NeuSAc),-nLc4Cer) and disialosyllacto-N-norhexaosylceramide ([DSnHC] V13(Neu5Ac),-nLc,Cer) were purified from pooled b u~ coats as follows: A crude lipid extract was prepared as previously d e~r i b e d '~ and partitioned according to the method of Folch et al." Folch upper phase (UP) was dialyzed, lyophilized, taken up in 1 L chloroform-methanol-water (C-M-W) 30/60/8 (vol/vol/vol), and passed through a 3 X 20-cm DEAE Sepharose column (acetate form, Pharmacia, Freiburg, Germany). Noncharged lipids were eluted with 2.5 L C-M-W 30/60/8 (vol/vol/vol) and 2.5 L methanol. Gangliosides were eluted consecutively, each with 2 L of 10,20,30,50,80, 150, and 300 mmol/L ammonium acetate in methanol, respectively. All disialogangliosides were found in the 50-mmol/L fraction. After desalting, the disialogangliosides were separated on a high-performance liquid chromatography (HPLC) column (16 X 500 mm, Knauer, Berlin, Germany) filled with Lichrosorb Si 60 5 pm silica. Elution was performed essentially as previously described" using a gradient from 2-propanol-hexane-water (iP-H-W) 55/42/3 (vol/ vol/vol) to iP-H-W 70/10/20 in 600 minutes at a flow rate of 1.5 mL/min; 200 fractions were collected. DSPG and DSnHC peaked in fraction 138 and 152, respectively. Their structures were confirmed by fast atom bombardment mass spectrometry, immunostaining using mAb BP-GD3 (specific for GD3 and neolacto gangliosides with a terminal disialosyl group), and immunostaining of their desialylated backbones with mAb 1B2, which is specific for GSLs of the neolacto series. The asialo derivatives were identical with respect to their mobility on thin-layer chromatography (TLC) and immunostaining by MoAb 1B2 to paragloboside (nLc,Cer) and lacto-N-norhexaosylceramide (nLc,Cer), respectively.
Lactosylceramide (Laser) and nLc.,Cer were prepared from Folch lower phase of the buffy coat extract as previously described.36 nLc,Cer was obtained from 2,3 sialosyl lacto-N-norhexaosylceramide (VI'NeuSAc-nLc,Cer) by cleavage with Vibrio cholerae ~ialidase.~, Unseparated leukocytes, 1.7 X 10l2 stored separately in 1 1 batches of 1 to 2 X 10" cells in methanol at -70°C before glycolipid purification, were stirred in batches in 500 mL methanol and sonified in 5 X 1-minute intervals in an ice bath using a Branson sonifier B-12 (Heinemann, Schwabisch Gmiind, Germany) at 100 W. Cell homogenates were filtrated and the filter cakes were resuspended in 500 mL C-M 1/2 (vol/vol) and reextracted in the same manner; a third extraction was performed with C-M 2/1 (vol/vol). The lipid extracts were evaporated in vacuo and partitioned essentially according to the method of Folch et a134 using 100 mL C-M 2/1 and 20 mL water. The lower phases were partitioned again with the same volume of UP. By immunostaining (see below), it was found that the UP after this second partition (2nd UP) contained the vast majority of the CDw60-bearing glycolipids, whereas the bulk of the more polar glycolipids was concentrated in the first UP (1st UP). Some very polar CDw60 antigens were also found in the I st UP, but their amount seemed to be very low. Therefore, the two UPS were not combined as usual and only the 2nd UP was used for further purification; it was evaporated and dialyzed for 72 hours against cold water (4°C). In our hands, this procedure proved to be more efficient for desalting ofthe 2nd UP than use ofa C,, reversed-phase column. The desalted 2nd UP was then passed over a DEAE Sepharose column (acetate form, 3 X 5 cm) washed with 1 L C-M-W 30/60/8 (vol/vol/vol) and I L methanol. Monosialogangliosides, disialogangliosides, trisialogangliosides, and polysialogangliosides were each eluted with 1 L of 20, 80, 150, and 500 mmol/L ammonium acetate in methanol, respectively, and the eluates were evaporated to dryness (25°C). Care was taken to avoid acidic conditions during evaporation by adding small portions of solid sodium hydrogen carbonate. The material was dialyzed, lyophilized, and stored at -70°C. The disialoganglioside fraction contained 208 jtg lipidbound sialic acid.
Glycolipid isolation from defined human leukocyte populations. Purified leukocytes ( 1 to 5 X 10' cells) stored in 5 mL methanol at -70°C were extracted with 2 X 5 mL methanol for 5 minutes in an ultrasonic bath and twice with 5 mL C-M 2/1 (vol/vol). The extracts were then evaporated to dryness and partitioned in 5 mL C-M 2/1 and 1 mL water. The lower phase was reextracted with 3 mL M-W 1/1 (vol/vol); both UPS were combined and dried. WaterPurification of CDw60 glycolipid antigens from leukocytes.
For personal use only. TLC. Alkali-labile gangliosides were detected according to the method of Sonnino et al.38 The ganglioside mixture was spotted as a small circle close to an edge ofthe HPTLC plate. After development in the first dimension, the plate was dried and treated with ammonia as described below; the plates were then run perpendicularly to the first dimension.
Ammonia twatmenl qfgang1ioside.s. AI kaline hydrolysis of gangliosides previously separated on HPTLC plates was performed by incubating the plates in a chamber saturated with concentrated aqueous ammonia for 17 hours at ambient temperature. Before a second TLC run (when a two-dimensional separation was to be performed), the ammonia-treated plate was dried for at least I hour in vacuo in the presence of P20,.
TLC immlmostaining This method, originally described by Magnani et was performed as previously describedN with some modifications!' CDw60 MoAbs were used as I:200-diluted ascites fluid in PBS containing 1% bovine serum albumin ([BSA] wt/vol) and 0.05% sodium azide (PBS/BSA). MoAb BP-GD3 was adjusted to I pg/mL antibody with PBS/BSA; MoAb RB13-229 was used as an undiluted culture supernatant.
Immimochcmical dclection of GSL on TLC. All reagents were purchased from Boehringer Mannheim, Mannheim, Germany. TLC digoxigenin-3-0-succinyl-~-aminocaproic acid hydrazide (DIG) staining was performed essentially as previously described?2 but somewhat modified. To obtain an improved sensitivity, a 37-pmol/L solution of DIG was used and the anti-digoxigenin antibody ( I :200 diluted) was allowed to incubate for 48 hours at 30°C. In a variant of the TLC DIG staining, the glycerol side chain ofthe neuraminic acid component of gangliosides was oxidized selectively (the other cis diol groups ofthe ganglioside molecule were not im~aired)~' usinga 3-mmol/L solution ofsodium periodate in PBS, pH 7.3. Oxidation was performed in the dark for I hour at 0°C. Total gangliosides were detected by TLC DIG staining after treatment with ammonia as described previously.
Mild base treatmen! ofgang1ioside.s. After TLC separation of the gangliosides, the plate was fixed with polyisobutylmethacrylate as previously describedN and incubated with 100 mmol/L glycineNaOH buffer, pH 10.0, at 37°C for 2 hours.
Qiianf//icafion. For quantification of gangliosides after TLC, the resorcinol/HCl-sprayed HPTLC plates were heated for 30 minutes at 95°C and measured densitometrically in transmission mode at 580 nm" using a Shimadzu (Duisburg, Germany) dual-wavelength TLC Scanner CS9001 PC; 0.5 to 3.0 pg G,, was used for calibration. Densitometric quantification of 9-0-acetyl G, , after TLC immunostaining was performed using calibration curves obtained with 0.25 to 25 ng antigen and densitometric measurement of the indigo-like phosphatase stain at 600 nm in transmission mode. Peak area values and antigen levels showed a logarithmic relationship in a limited range (-I to 520 ng antigen). (Fig I , lane a) .
RESULTS

Characterization
To confirm the presence of 9-0-acetyl GD3 in human leukocytes and to characterize the additional antigens recognized by MoAb M-T2 I , GSLs from whole-blood leukocytes were prepared. We started with 1.7 X 10l2 leukocytes and used only a few separation steps to minimize the loss of 0-acetylated gangliosides, which are supposed to be the carriers of the CDw60 carbohydrate e p i t~p e .~~ Purification of the GSLs was monitored using specific TLC immunostaining with MoAb M-T2 I, allowing the detection of 9-0-acetyl GD3 at an amount as low as 0.2 to 0.4 ng. In addition, a nonspecific immunochemical GSL detection method was used, namely TLC DIG This method involves periodate oxidation of the GSL, which generates aldehyde groups; these are treated with DIG. The digoxigenin component is visualized by an antidigoxigenin antibody conjugated with alkaline phosphatase. TLC DIG staining is suitable especially for the detection of trace amounts of neutral glycolipids and gangliosides. Since the exocyclic (glycerol) side chain of neuraminic acid is more sensitive to periodate oxidation than other parts of the ganglioside m0lecules,4~ DIG staining of gangliosides can be performed using especially mild oxidation conditions (3 mmol/L periodate at 0°C and pH 7.3 for 60 minutes instead of IO mmol/L periodate at 30°C and pH 5.5 for 30 minutes as in the standard p r~c e d u r e ) .~~ In 9-0-acetylated gangliosides, oxidation of the exocyclic side chain of the terminal neuraminic acid is prevented. They are stained only after removal ofthe O-acetyl group with ammonia. Thus mild TLC DIG staining with For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From and without preceding ammonia treatment was used to screen for-and to support the presence of-9-0-acetylated gangliosides.
Nearly all ofthe antigens recognized by mAb M-T2 1 were found in the UP after the 2nd Folch solvent partition; the GSLs were then separated on a DEAE Sepharose column. M-T2 1 antigens (Fig 2) were found in the disialoganglioside fraction. Neither the bands at the positions of the M-T2 I antigens nor any other disialogangliosides could be seen after TLC DIG staining (Fig 2, right) . Only three faintly stained double bands were detected (only two of them can be seen in the photograph) by TLC DIG staining when a larger amount of the disialoganglioside fraction was analyzed (Fig 3, -) . Immunostaining using MoAb BP-GD3 and comparison with standard glycolipids indicated that the u p per double band represented G,,, the lower double band DSnHC, and the double band between them (not visible on this photograph) DSPG, respectively (not shown). Treatment of this fraction with ammonia before TLC DIG staining showed several additional gangliosides (Fig 3, +) , suggesting an abundance of alkali labile 0-acetylated gangliosides. Immunostaining of the disialoganglioside fraction with MoAb M-T2I produced several bands, especially at higher antigen concentrations (Fig 4, -lanes) . Ammonia treatment of disialogangliosides before immunostaining decreased both the number and intensity of the M-T2 1 immunostained bands (Fig 4, + lanes) . Three double bands were recognized with MoAb M-T21 in the alkali-treated disialogangliosides; these comigrated with the disialogangliosides G,,, DSPG, and DSnHC, respectively (Fig4; ganglioside designations and structures are shown in Table I ). As will be demonstrated below, these three gangliosides were also stained by MoAb BP-GD3, which is specific for GD3 and for terminally disialylated gangliosides of the neolacto series such as DSPG and DSnHC.
To improve resolution of the disialogangliosides and to identify the degradation products and structural diversities of the 0-acetylated CDw60 antigens, an aliquot of the disialoganglioside fraction was separated using twodimensional TLC." The disialogangliosides, containing alkali-stable as well as the alkali-labile 0-acetylated forms, were chromatographed in the first dimension and then the TLC plate was exposed to ammonia vapor to remove the O-acetyl groups. The formerly 0-acetylated gangliosides were then developed perpendicularly to the first dimension. The deacetylated gangliosides were found at a position perpendicular to the position to which they had migrated in the first dimension in their 0-acetylated form. The deacetylated gangliosides could then be compared with standard gangliosides. They were detected by immunostaining with MoAb BP-GD3 ( Fig 5A) ; the components were designated with numbers (Fig 5B) .
Because the chromatographic mobility ofthe alkali-stable gangliosides is not influenced by ammonia treatment, they appear on a line through the starting point. The components 1,2,9, IO, 13, and 14 ( Fig 5B) were found on such a line (Fig 5A) and thus represented the alkali-stable gangliosides. Presumably due to a heterogeneity in their lipophilic moiety, the gangliosides appeared as double spots; the double spots I + 2, 9 + IO, and 13 + 14 (Fig 5B) migrated like the standard gangliosides GDS, DSPG, and DSnHC, respectively (Fig 5A) .
All gangliosides not found on the line through the starting point must have changed their mobility after ammonia treatment and were therefore considered to originate from alkali-labile (0-acetylated) forms. The presence of ganglioside lactones, which form another large group of alkali-labile gangliosides, could be excluded because disialoganglioside lactones would have been found in the monosialoganglioside or the neutral GSL fraction, respectively.
Most of the disialogangliosides derived from alkali-labile forms were found on a line parallel to the line of al kali-resistant gangliosides (spots 5 + 6, 1 I + 12, and I6 + 17 in Fig   5B) . In addition, there were spots lying between the two lines (3, 4 , and 15, difficult to see in this figure), and two spots (7 and 8) were located beyond the ''line'' of most of the alkali-labile gangliosides (Fig 5A) .
When the disialogangliosides were separated as shown in although the mobility of their acetylated forms was different. Similarly, the double spots 1 1 + 12 and 16 + 17 originated from DSPG and DSnHC, respectively (Fig 5) .
Since the 0-acetylated gangliosides were deacetylated during the twodimensional TLC separation, a direct analysis of their immunologic properties could not be performed after this step. On the other hand, the disialogangliosides, due to the existence of nonacetylated and several acetylated forms, would not be separable using onedimensional TLC as shown in Fig 5. After TLC in the first dimension, G,, comigrated with the acetylated form of DSPG (Fig 5, spots 1  and 1 I ) and DSPG with the acetylated form of DSnHC (Fig  5 , spots 9 and 16) , respectively.
Indirect evidence for the identity of the main O-acetylated disialogangliosides was obtained as follows: by drop ping perpendicular projections from the double spots 5 + 6, 1 1 + 12, and 16 + 17 derived from the most abundant 0-acetylated gangliosides in the two-dimensional TLC (Fig  5) , it is obvious that these GSLs were already separated from each other in the first-dimension chromatogram. Thus the projected six spots can be precisely aligned with and thereby most likely correspond to the specifically immunostained bands of 0-acetylated gangliosides in onedimensional TLC as shown in Fig 6G, right. Immunostaining of the disialogangliosides with MoAb RB13-2, an antibody specific for 9-0-acetyl G,3,29 in fact detected three well-separated double bands (Fig 6G, right) located at the same positions as expected for the main 0-acetylated disialogangliosides ( Fig  5A) . These three double bands were also seen in Fig 4 with MoAb M-T2 1 at a low antigen concentration (Fig 4, lane A, 
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The ganglioside doublets 5 + 6, I 1 + 12, and 16 + 17 therefore appeared to originate from the 9-0-acetylated forms of G,,, DSPG, and DSnHC, respectively. This conclusion was also confirmed by the relative stability of these GSLs to mild periodate oxidation. Periodate treatment of the disialogangliosides directly on the HPTLC plate had no effect on the MoAb RB 13-2 staining pattern, indicating that this MoAb specifically detected not only 9-0-acetylated forms of G, , but also 9-0-acetylated DSPG and DSnHC (not shown).
Minor alkali-labile disialogangliosides 7 + 8 (Fig 5 ) could only be tentatively identified. We recently detected a di-0- .1 2 fig, (C) 0.25 fig, (D) ---------s -- f Tentative identification due to the slightly higher mobility compared with the mono-0-acetylated sample. This behavior was very similar to a recently characterized di-0-acetylated GD3 from bovine b~t t e r m i l k .~~ acetylated derivative of GD3 in bovine b~ttermilk?~ which, compared with 9-0-acetyl G,, , had a slightly increased mobility and also appeared to be recognized by CDw60
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MoAbs. In analogy to this finding, ganglioside doublet 7 + 8 could be a di-0-acetylated GD3.
The components 3 + 4 and 15 were also derived from alkali-labile forms of G, , and DSnHC, respectively (Fig 5) .
The mobility of spots 3 + 4 was very similar to that of GD3 (spots 1 + 2), and they were therefore difficult to distinguish from each other. As will be shown below, the original alkalilabile form of spots 3 + 4 was presumably not recognized with CDw60 mAbs. Due to the dense conglomeration of spots near G,, (Fig SA) , the existence of additional O-acetylated derivatives of GD3 different from the three alkali-labile G, , forms described here cannot be ruled out. The existence of such derivatives, very similar in their chromatographic mobility but not identical to GD3, could be an explanation for the discrepancy observed when the relative amounts of 0-acetylated forms in the whole disialoganglioside fraction, as shown in Figs 3 and 5, respectively, were compared. According to Fig 3, spots 1 + 2, especially the part lying between the two lines in Fig 5A , might have originated from an unknown GD3 derivative. Such a derivative could in fact be detected after pretreatment of the TLC-separated disialogangliosides with mild alkali (pH 10 buffer) followed by immunostaining with a CDw60 MoAb (Fig 7A +) . The new intensively stained band migrated just below 9-0-acetyl GD3 (Fig 7A +) and was clearly different from GD3, since it could be detected with MoAb UM4D4, which binds only to O-acetylated forms of GD3,24 This new 0-acetylated CDw60 antigen seemed to be derived from a GD3 derivative that was not detected by CDw60 mAbs. Recently, Manzi et a145 reported for the first time the presence of 7-0-acetyl GD3 in human melanoma cells and reported evidence that 9-0-acetyl GD3-specific MoAbs did not recognize the 7-0-acetylated isomer. In view ofthis finding together with the well-known tendency of the 7-0-acetyl group to migrate to the 9-psition,& the alkali-labile unknown GD3 derivative could be a 7-0-acetylated GD3.
Some other CDw60 antigens, presumably the long-chain analogs of the same types as described above such as VIII3(Neu5Ac),-nLcsCer and its 9-0-acetylated form, may also be present in minor quantities in the disialoganglioside fraction of human leukocytes.
Antigen specificity of CDw60 MoAbs. We have previously shown that all CDw60 MoAbs bind preferentially to 9-0-acetyl GDj isolated from bovine buttermilk and also to a di-0-acetylated form of GD3.24 This can now be extended to the long-chain analogs of 9-O-acetyl GD3, 9-O-acetyl DSPG, and 9-0-acetyl DSnHC and probably also to 9-0-acetylated disialogangliosides having even longer carbohydrate chains. In general, all CDw60 MoAbs bound to 9-0-acetylated forms of GD3 and the 9-0-acetylated neolacto gangliosides DSPG and DSnHC, respectively; differences were found in their binding to nonacetylated gangliosides. Recently, we found that MoAb UM4D4 bound only to acetylated GD3, whereas the other CDw60 MoAbs, M-T2 1, M-T32, and M-T4 1 also showed some reactivity with nonacetylated GD3, which was only seen at about 50-to 100-fold higher antigen concentrations than those needed for binding to 9-0-acetyl GD3.24 This reactivity was also observed for non-0-acetylated DSPG and DSnHC (Fig 4) . 
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The structures of the disialogangliosides identified in human leukocytes and their reactivity with CDw60 MoAbs are summarized in Table 1 .
Expression of CDw60f gangliosides by diflerent human leukocyte populations. Having identified various CDw60-reactive gangliosides in unseparated human blood leukocytes, it remained to be shown whether they were differentially distributed in leukocyte subpopulations. This seemed an important question, particularly in view of the rather restricted cell surface expression of CDw60 antigens, which, among hematopoietic cells, are only found on functional subsets of T lymphocyte^.'^ To this end, lipid extracts were prepared from various purified leukocyte populations and immunostained after TLC separation with the MoAbs M-T21 (Fig 6) (left) and UM4D4 (middle) and the 9-O-acetyl GD3 specific reference MoAb RB 13-2 (right), respectively. As shown in Fig 6 ( (Fig 6, left, lane F) . This was not surprising since it is known that granulocytes contain more than 90% of the glycolipids of all leukocyte^.^^ Thymocytes appeared to contain G, (Fig 6, left, lane A) . As 9-0-acetylated DSPG and GD3 migrate together on TLC (Fig 5B, spots 1 and 11 or 2 and 12), we confirmed the identity of the lower immunostained band in the lipid extract of thymocytes as GD3 by immunostaining with the BP-GD3 antibody (not shown). The presence of GD3 in thymocytes has been de~cribed.'~ From the staining pattern it was evident that besides granulocytes (Fig 6, left, lane F) , T cells (Fig 6, left, lane B) produced the strongest staining. Immunostaining of the same lipid extracts with MoAb UM4D4 (Fig 6, middle) showed bands in T cells, B cells, and granulocytes but not in thymocytes and monocytes as detected with MoAb M-T2 l . The serological preference of CDw60 mAb for a subpopulation of human T cells was partially reflected by the extent of their binding to lipid extracts from separated leukocytes. MoAb UM4D4 showed the most confined specificity. The fastestmoving ganglioside band comigrated with 9-0-acetyl GD3 (lane H). Binding of MoAb UM4D4 to 9-0-acetylated gangliosides was confirmed when we compared the UM4D4 pattern with that obtained with MoAb RB 13-2 (Fig 6, right) ; both patterns were nearly identical.
The total amount of 9-0-acetyl GD3 per lo7 cells of the purified leukocytes is represented in Table 2 .
DISCUSSION
This study presents an analysis ofthe structures and cellular distribution ofthe GSLs with CDw60 antigenic determinants in human leukocytes. A structural family of gangliosides was detected that so far has not been recognized in normal human leukocytes, namely the 0-acetylated disialogangliosides of the neolacto series. The occurrence of these alkali-labile gangliosides in normal human leukocytes Values obtained by densitometric scanning at 600 nm after TLC immunostaining using MoAb UM4D4.
might have been overlooked before, since the conventional purification procedures for GSLs often include mild alkaline hydrolysis for removal of phospholipids or ion-exchange chromatography with an eluent containing alkaline sodium acetate.
In the present investigation, we avoided alkaline hydrolysis and used neutral ammonium acetate as an eluent. Despite these precautions, it was not possible to quantify exactly the proportion of acetylated and nonacetylated forms of disialogangliosides originally present in leukocytes, since it could not be excluded that 0-acetylated gangliosides were deacetylated during our glycolipid purification. The total amount of disialogangliosides that could be isolated from leukocytes was rather low. In these experiments, 122 pg lipid-bound sialic acid was obtained from 10"unseparated blood leukocytes. This finding, together with the observation that several different gangliosides had identical mobilities, has so far hampered a more detailed analysis of these molecules.
However, two-dimensional TLC combined with immunologic detection has allowed a first structural characterization of these antigens, since the parental molecules from which the acetylated derivatives originated could easily be identified. The acetylation site of most of these antigens could be determined using the reference mAb RB13-2, which is specific for 9-0-acetyl GD3 . 29 The presence of di-0-acetylated CDw60 antigens (spots 7 + 8 in Fig 5) remains to be determined.
According to the TLC DIG stain, only a minority of the disialogangliosides were not 0-acetylated (Fig 3) , whereas two-dimensional TLC analysis seemed to indicate that a significant proportion of the disialogangliosides, especially of GD3, was not 0-acetylated (Fig 5) . These contradictory results led us to detect another acetylated GD3 derivative in human leukocytes. Due to the existence of only a small amount of non-0-acetylated GD3 in the disialoganglioside fraction of leukocytes (Fig 3) , the majority of the large GD3 spots (Fig 5, spots 1 and 2 ) was supposed to originate from an unknown derivative of GD3 after treatment with ammonia. The chromatographic mobility of this GD3 derivative could only be slightly greater than that of GD3. Thus the characteristic decrease in their chromatographic mobility after ammonia treatment, the most frequently used screening method for the detection of 0-acetylated gangliosides, was not suitable for the detection of this acetylated GD3 derivative. However, its presence could be unequivocally KNIEP ET AL demonstrated after its alkali-induced rearrangement to a CDw60 antigen (Fig 6) . The resulting antigen was detected with MoAb UM4D4 and was therefore 0-a~etylated.'~ The relative amount of unchanged G,, and GD3 released from the unknown 0-acetylated derivative after ammonia treatment, respectively, was estimated from the M-T2 1 immunostaining pattern. Separation and staining were performed at the same time as the separation shown in Fig 5. Due to the weaker binding of MoAb M-T2 1 compared with BP-GD3, the double spots originating from unchanged GD3 and the unknown G,, derivative, respectively, were somewhat easier to distinguish (not shown). Only about 20% of spots 1 + 2 were found on the line of the alkali-stable gangliosides (unchanged G,,), and the remaining 80% seemed to originate from the GD3 derivative. This suggested that GD3, in contrast to its 0-acetylated forms, was a minor-occumng disialoganglioside in human leukocytes.
CDw60 antigens were then analyzed in separated leukocyte populations. With the exception of granulocytes, the CDw60 immunostaining patterns were simple, so that in this case quick identification ofthe major CDw60 antigen as 9-0-acetyl GD3 was possible. Staining with the 9-0-acetyl G,,-specific reference antibody RB 1 3-2 confirmed that the CDw60 MoAbs detected preferentially 9-0-acetylated disialogangliosides (Fig 6) . T cells and granulocytes contained most of the CDw60 antigens; however, by immunofluorescence surface staining CDw60 antigens are detected on T lymphocytes, but not on other cells. 23 The reason for this is not yet clear. It may be due to varying degrees of accessibility of the CDw60 determinants in the cell membrane of the separate leukocyte subsets or to a disparate localization of the CDw60 antigens within cells of different lineages. 9-0-acetyl GD3 has been described as a melanoma-associated antigen in h~m a n s ,~~'~' b u t so far it has not been reported to be a leukocyte antigen. In keeping with the presence of 0-acetylated gangliosides in lymphocytes, Kamerling et identified 0-acetylated sialic acids in the hydrolysates of human B and T cells, and Holzhauser and Faillard4* found 9-0-acetyl neuraminic acid in trace quantities after mild acid treatment of normal lymphocytes and in large quantities after the same treatment in lymphocytes ofpatients with melanomas and mammary carcinomas.
With respect to the function of CDw60 antigens on cells of the immune system, a number of studies have been performed with the MoAb UM4D4" that suggest an important role for these antigens in T-cell activation. It has been claimed that the UM4D4 antigen is involved in a novel pathway of human T-lymphocyte activation and that it could play a role in the pathogenesis of autoimmune diseases such as rheumatoid a r t h r i t i~. '~,~~ Unlike other glycolipid antigens, which are preferentially localized at the cell surface, most of the UM4D4 antigens in human thymocytes were found in the ~ytoplasm.~' The mechanism leading to a selective enrichment or proliferation of UM4D4+ T cells in the synovial compartment and to their activation is not known. An interesting hypothesis" postulates the existence of a lectin-like adhesion receptor, eg, a lectin specific for 0-acetylated gangliosides, which could mediate both enrichment of CDw60+ T cells in the synovium and their permanent activation in this compartment.
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APPENDIX
NeuSAc, 5-N-acetyl neuraminic acid; Neu95, 9Ac2, 5-N-acety1, 9-0-acetyl neuraminic acid; G,,, I13(Neu5Ac),-LacCer, Neu5Ac a2 -+ 8Neu5Aca2 -+ 3GalPI + 4GlcPI -+ 1'-ceramide; 9-0-acetyl G,,, I13(Neu5,9Ac2-Neu5Ac)-LacCer, Neu5, 9Ac2a2 -+ 8Neu5-Aca2 -+ 3GalpI -+ 4GlcPI -+ 1'-ceramide; DSPG, disialosylparagloboside, IV3(Neu5Ac),-nLc,Cer, Neu5Aca2 + 8Neu5Aca2 -+ 3GalP1 -+ 4GlcNAc@l + 3GalPl -+ 4Glc01 -+ 1'-ceramide; 9-0-Ac DSPG, IV3(Neu5,9Ac,-Neu5Ac)-nLc,Cer, Neu5,9Ac2a2 -+ SNeu5Aca2 + 3GalPl + 4BlcNaCpl -+3GalpI + 4Blcpl -+ 1'-ceramide; DSnHC, disialosyllacto-N-norhexaosylceramide,V13-(NeuSAc),-nLc,Cer, Neu 5Aca2 -+ 8Neu5Aca2 -+ 3GalPI -+ 4GlcNAcPI -* 3GalPI -+ 4GlcNAc/3I -+ 4GlcNAcP1 -+ 3Gal Pl -.+ 4GIcfl1 -+ 1'-ceramide; 9-OAc DSnHC,V13(Neu5,9Ac,-Neu5Ac)-nLc,Cer,Neu5,9Ac2a2 -+ SNeu5Aca2 + 3GalpI + 4BlcNAcpI -+ 3GalP1 + 4GlcNAc@I + 3Galol + 4Glc@l -+ 1'-ceramide; LacCer, lactosylceramide, Gal@ I -+ 4GlcPl -+ 1'-ceramide: nLc,Cer, paragloboside,Galpl -* 4GlcNAcPI + 3Falpl -+ 4GlcBI -+ 1'-ceramide; nLc,Cer, lacto-N-norhexaosylceramide, Gal01 -+ 4GlcNAcpI -+ 3Galpl -+ 4GlcNCc@1 -+ 3GalpI -+ 4Glcp 1 + 1 '-ceramide.
Glycolipids are abbreviated according to the recommendations of the IUPAC-IUB Commission on Biochemical Nomenclature"; however, the suffix -0seCer is replaced by -Cer.
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